Reduced high-density lipoprotein antioxidant function in patients with coronary artery disease and acute coronary

Benjamin Sasko1,2, Linda Scharow3, Rhea Mueller2

  • 1Ruhr-University of Bochum, Medical Department II, Marien Hospital Herne, Bochum, Germany.

JCI Insight
|March 24, 2025
PubMed

Insights

Reduced HDL antioxidant function is linked to coronary artery disease (CAD). The nHDLox marker strongly predicts acute coronary syndrome (ACS), highlighting its role in cardiovascular pathogenesis.

Area of Science:

  • Cardiovascular Science
  • Biochemistry
  • Clinical Medicine

Background:

  • High-density lipoprotein (HDL) function, not just concentration, is crucial in coronary artery disease (CAD) pathogenesis.
  • Reduced HDL antioxidant function is implicated in cardiovascular disease.
  • The study investigated the association between HDL antioxidant function and stable CAD or acute coronary syndrome (ACS).

Purpose of the Study:

  • To determine if reduced HDL antioxidant function is associated with stable CAD.
  • To assess if reduced HDL antioxidant function is associated with acute coronary syndrome (ACS).
  • To evaluate nHDLox as a predictor for ACS and CAD.

Main Methods:

  • Assessed HDL antioxidant function using a cell-free biochemical assay measuring HDL-lipid peroxide content (HDLox).
  • Normalized HDLox by HDL-C levels and a healthy pooled serum control to derive nHDLox.
  • Analyzed nHDLox in two cohorts: elective coronary angiography patients (n=1225) and ACS patients (n=196).

Main Results:

  • Participants with CAD (n=723) showed 12% higher mean nHDLox levels than those without CAD (n=502; P < 0.001).
  • Patients with ACS exhibited the highest nHDLox values compared to the elective cohort (median 1.35, IQR 0.97-1.85; P < 0.001).
  • Multivariate analysis confirmed nHDLox as a strong independent predictor of ACS (P < 0.001) but not of CAD (P > 0.05).

Conclusions:

  • HDL antioxidant function is diminished in patients with CAD.
  • The nHDLox marker is strongly associated with acute coronary syndrome (ACS).
  • nHDLox may serve as a valuable biomarker for identifying patients at risk of ACS.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
484
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
429
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
475
Inflammation01:38

Inflammation

Overview
52.1K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
111